Drugs for metabolic diseases, vaccines, and cancer therapies feature ... which could become the first drug in the PROteolysis Targeting Chimera (PROTAC) class to reach the market.

This includes ABRYSVO® (Respiratory Syncytial Virus Vaccine), which in October 2024 ... free survival – – Vepdegestrant is the first PROTAC degrader to demonstrate clinical benefit in ...

Any hopes that Mr. Kennedy’s noxious views on vaccines would moderate with responsibility were always wishful thinking. It may be impossible to change his course, but that doesn’t mean those ...

Kennedy Jr. presented himself as a supporter of vaccines. But in office, he and the agencies he leads have taken far-reaching, sometimes subtle steps to undermine confidence in vaccine efficacy ...

The Centers for Disease Control and Prevention is expected to hand over multiple sets of vaccine safety data to a discredited researcher with a history of spreading misinformation that vaccines ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen ...

Messenger Ribonucleic Acid (mRNA) vaccines gained global recognition during the Coronavirus Disease 2019 (COVID-19) pandemic, proving their value through rapid development, high efficacy ...

Just last week, the US Food and Drug Administration delayed a decision on full approval of Novavax’s Covid-19 vaccine even though it was on track to be cleared, leaving many public health ...

Did you know that Medicare fully covers a number of vaccines for its beneficiaries? Well, they do. All adult vaccines recommended by the Centers for Disease Control's (CDC) Advisory Committee on ...

A new Cleveland Clinic study conducted in the United States on the flu vaccine has grabbed vaccine sceptics’ interest, prompting questions and concerns about the vaccine’s safety.